معرفی
Andrew S. Weyrich is an Adjunct Professor in the Department of Internal Medicine at the University of Utah, where he also serves as Vice President for Research and President of the University Research Foundation. His research investigates how platelets regulate thrombosis and inflammation through mRNA splicing and translational control, a field now recognized as "thromboinflammation."
Education History:
- Postdoctoral Fellowship at University of Utah (Nora Eccles Harrison CVRTI)
- Postdoctoral Fellowship at Thomas Jefferson University
- PhD from Bowman Gray School of Medicine
- MA from Wake Forest University
- BS from Baldwin-Wallace College
Research Interests center on platelet biology, thrombosis, inflammation, and molecular mechanisms of anucleate cell function. His group discovered signal-dependent pre-mRNA splicing in platelets, redefining understanding of non-genomic regulatory processes in blood clotting and immune responses.
Recent Publications address miRNA regulation in GPVI signaling, platelet abnormalities in neurodegenerative diseases, glucose metabolism roles in thrombosis, and platelet microparticle interactions with tumors. Keywords span Hematology, Molecular Biology, and Translational Medicine.
Scientific Awards include the prestigious William Dameshek Prize (ASH), H.A. and Edna Benning Presidential Endowed Chair, and John R. Hoidal Senior Investigator Award. He also serves on the NIH NHLBI Advisory Council.
As a mentor, Dr. Weyrich directs training grants for medical students and postdoctoral fellows. His leadership at the University of Utah has driven research growth, safety initiatives, and programs addressing the opioid crisis, equity in research, and pandemic responses like COVID-19 surveillance testing.
